Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 13;13(2):513.
doi: 10.3390/life13020513.

Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets

Eloisa Romano  1 , Irene Rosa  2 , Mirko Manetti  2
Affiliations
Editorial

Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets

Eloisa Romano et al. Life (Basel). .

Abstract

Systemic sclerosis (SSc, or scleroderma) is a multifaceted rare connective tissue disease [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

  • Biomarkers in Systemic Sclerosis: An Overview.
    Di Maggio G, Confalonieri P, Salton F, Trotta L, Ruggero L, Kodric M, Geri P, Hughes M, Bellan M, Gilio M, Lerda S, Baratella E, Confalonieri M, Mondini L, Ruaro B. Di Maggio G, et al. Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490. Curr Issues Mol Biol. 2023. PMID: 37886934 Free PMC article. Review.

References

    1. Asano Y. The pathogenesis of systemic sclerosis: An understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies. J. Clin. Med. 2020;9:2687. doi: 10.3390/jcm9092687. - DOI - PMC - PubMed
    1. Romano E., Rosa I., Fioretto B.S., Matucci-Cerinic M., Manetti M. The role of pro-fibrotic myofibroblasts in systemic sclerosis: From origin to therapeutic targeting. Curr. Mol. Med. 2022;22:209–239. doi: 10.2174/0929867328666210325102749. - DOI - PubMed
    1. Rosa I., Romano E., Fioretto B.S., Matucci-Cerinic M., Manetti M. Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis. World J. Stem Cells. 2021;13:30–48. doi: 10.4252/wjsc.v13.i1.30. - DOI - PMC - PubMed
    1. Villanueva-Martín G., Martín J., Bossini-Castillo L. Recent advances in elucidating the genetic basis of systemic sclerosis. Curr. Opin. Rheumatol. 2022;34:295–301. doi: 10.1097/BOR.0000000000000897. - DOI - PubMed
    1. Varga J., Trojanowska M., Kuwana M. Pathogenesis of systemic sclerosis: Recent insights of molecular and cellular mechanisms and therapeutic opportunities. J. Scleroderma Relat. Disord. 2017;2:137–152. doi: 10.5301/jsrd.5000249. - DOI

Publication types

LinkOut - more resources